2009 Atrial Fibrillation Therapy: Clinician Perspectives

 

Regular Price: USD 10,000

Special Price USD 7,000

30% OFF

* Required Fields

Regular Price: USD 10,000

Special Price USD 7,000

PAY BY INVOICE

Be the first to review this product

The objectives of this research were to identify the perceptions, attitudes, usage patterns, and preferences of doctors in relation to treatment options for Atrial Fibrillation, determine catheter and surgical ablation product attributes that are perceived to be important, including energy modality, ease-of-use, and other potential drivers of satisfaction or dissatisfaction, determine the key drivers of adoption and non-adoption of surgical cardiac ablation and determine the clinical brand preferences and the perceived strengths of brands.

Table of Contents

2009 Atrial Fibrillation Therapy, Atrial Fibrillation TechnologiesAblation TechnologiesClinician Analysis




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 22-Nov-17

Region : North America

Release Date : 21-Nov-17

Region : North America

Release Date : 20-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.